These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
305 related items for PubMed ID: 25446569
1. Naringenin reduces cholesterol-induced hepatic inflammation in rats by modulating matrix metalloproteinases-2, 9 via inhibition of nuclear factor κB pathway. Chtourou Y, Fetoui H, Jemai R, Ben Slima A, Makni M, Gdoura R. Eur J Pharmacol; 2015 Jan 05; 746():96-105. PubMed ID: 25446569 [Abstract] [Full Text] [Related]
2. Dietary modification dampens liver inflammation and fibrosis in obesity-related fatty liver disease. Larter CZ, Yeh MM, Haigh WG, Van Rooyen DM, Brooling J, Heydet D, Nolan CJ, Teoh NC, Farrell GC. Obesity (Silver Spring); 2013 Jun 05; 21(6):1189-99. PubMed ID: 23666886 [Abstract] [Full Text] [Related]
4. The indole derivative NecroX-7 improves nonalcoholic steatohepatitis in ob/ob mice through suppression of mitochondrial ROS/RNS and inflammation. Chung HK, Kim YK, Park JH, Ryu MJ, Chang JY, Hwang JH, Lee CH, Kim SH, Kim HJ, Kweon GR, Kim KS, Shong M. Liver Int; 2015 Apr 15; 35(4):1341-53. PubMed ID: 25443620 [Abstract] [Full Text] [Related]
5. Thymoquinone alleviates nonalcoholic fatty liver disease in rats via suppression of oxidative stress, inflammation, apoptosis. Awad AS, Abd Al Haleem EN, El-Bakly WM, Sherief MA. Naunyn Schmiedebergs Arch Pharmacol; 2016 Apr 15; 389(4):381-91. PubMed ID: 26753695 [Abstract] [Full Text] [Related]
6. Naringenin alleviates nonalcoholic steatohepatitis in middle-aged Apoe-/-mice: role of SIRT1. Hua YQ, Zeng Y, Xu J, Xu XL. Phytomedicine; 2021 Jan 15; 81():153412. PubMed ID: 33234364 [Abstract] [Full Text] [Related]
7. Involvement of hepatic peroxisome proliferator-activated receptor α/γ in the therapeutic effect of osthole on high-fat and high-sucrose-induced steatohepatitis in rats. Zhao X, Xue J, Wang XL, Zhang Y, Deng M, Xie ML. Int Immunopharmacol; 2014 Sep 15; 22(1):176-81. PubMed ID: 24993341 [Abstract] [Full Text] [Related]
8. Total aralosides of aralia elata (Miq) seem (TASAES) ameliorate nonalcoholic steatohepatitis by modulating IRE1α-mediated JNK and NF-κB pathways in ApoE-/- mice. Luo Y, Dong X, Yu Y, Sun G, Sun X. J Ethnopharmacol; 2015 Apr 02; 163():241-50. PubMed ID: 25655997 [Abstract] [Full Text] [Related]
9. Epigallocatechin gallate attenuates fibrosis, oxidative stress, and inflammation in non-alcoholic fatty liver disease rat model through TGF/SMAD, PI3 K/Akt/FoxO1, and NF-kappa B pathways. Xiao J, Ho CT, Liong EC, Nanji AA, Leung TM, Lau TY, Fung ML, Tipoe GL. Eur J Nutr; 2014 Feb 02; 53(1):187-99. PubMed ID: 23515587 [Abstract] [Full Text] [Related]
10. Beneficial effects of naringenin in liver diseases: Molecular mechanisms. Hernández-Aquino E, Muriel P. World J Gastroenterol; 2018 Apr 28; 24(16):1679-1707. PubMed ID: 29713125 [Abstract] [Full Text] [Related]
11. Naringenin ameliorates renal and platelet purinergic signalling alterations in high-cholesterol fed rats through the suppression of ROS and NF-κB signaling pathways. Chtourou Y, Kamoun Z, Zarrouk W, Kebieche M, Kallel C, Gdoura R, Fetoui H. Food Funct; 2016 Jan 28; 7(1):183-93. PubMed ID: 26565065 [Abstract] [Full Text] [Related]
12. Chinese herbal medicine mixture 919 syrup alleviates nonalcoholic fatty liver disease in rats by inhibiting the NF-κB pathway. Chen M, Xing J, Pan D, Peng X, Gao P. Biomed Pharmacother; 2020 Aug 28; 128():110286. PubMed ID: 32521450 [Abstract] [Full Text] [Related]
13. Naringenin attenuates the release of pro-inflammatory mediators from lipopolysaccharide-stimulated BV2 microglia by inactivating nuclear factor-κB and inhibiting mitogen-activated protein kinases. Park HY, Kim GY, Choi YH. Int J Mol Med; 2012 Jul 28; 30(1):204-10. PubMed ID: 22552813 [Abstract] [Full Text] [Related]
14. Ameliorative effect of nicorandil on high fat diet induced non-alcoholic fatty liver disease in rats. Elshazly SM. Eur J Pharmacol; 2015 Feb 05; 748():123-32. PubMed ID: 25542756 [Abstract] [Full Text] [Related]
15. Curcumin ameliorates liver damage and progression of NASH in NASH-HCC mouse model possibly by modulating HMGB1-NF-κB translocation. Afrin R, Arumugam S, Rahman A, Wahed MI, Karuppagounder V, Harima M, Suzuki H, Miyashita S, Suzuki K, Yoneyama H, Ueno K, Watanabe K. Int Immunopharmacol; 2017 Mar 05; 44():174-182. PubMed ID: 28110063 [Abstract] [Full Text] [Related]
16. Alpinetin improved high fat diet-induced non-alcoholic fatty liver disease (NAFLD) through improving oxidative stress, inflammatory response and lipid metabolism. Zhou Y, Ding YL, Zhang JL, Zhang P, Wang JQ, Li ZH. Biomed Pharmacother; 2018 Jan 05; 97():1397-1408. PubMed ID: 29156529 [Abstract] [Full Text] [Related]
17. The Glucagon-Like Peptide-1 Analogue Liraglutide Inhibits Oxidative Stress and Inflammatory Response in the Liver of Rats with Diet-Induced Non-alcoholic Fatty Liver Disease. Gao H, Zeng Z, Zhang H, Zhou X, Guan L, Deng W, Xu L. Biol Pharm Bull; 2015 Jan 05; 38(5):694-702. PubMed ID: 25947915 [Abstract] [Full Text] [Related]
18. PPARα/γ agonists and antagonists differently affect hepatic lipid metabolism, oxidative stress and inflammatory cytokine production in steatohepatitic rats. Zhang Y, Cui Y, Wang XL, Shang X, Qi ZG, Xue J, Zhao X, Deng M, Xie ML. Cytokine; 2015 Sep 05; 75(1):127-35. PubMed ID: 26194065 [Abstract] [Full Text] [Related]
19. Persimmon tannin accounts for hypolipidemic effects of persimmon through activating of AMPK and suppressing NF-κB activation and inflammatory responses in high-fat diet rats. Zou B, Ge ZZ, Zhang Y, Du J, Xu Z, Li CM. Food Funct; 2014 Jul 25; 5(7):1536-46. PubMed ID: 24841999 [Abstract] [Full Text] [Related]
20. Ameliorative potential of omega 3 fatty acids and HMG-CoA reductase inhibitors on experimentally-induced non-alcoholic steatohepatitis. Kabel AM, Abd Elmaaboud MA, Albarraq AA. Prostaglandins Leukot Essent Fatty Acids; 2015 May 25; 96():1-9. PubMed ID: 25541279 [Abstract] [Full Text] [Related] Page: [Next] [New Search]